Bovine Colostrum Market Set to Reach $4.3 Billion by 2027 Amid Rising Demand for Immunity-Boosting Functional Foods

The bovine colostrum market is witnessing significant growth, driven by increased awareness of its health benefits, particularly its immunity-boosting properties. As a result, companies in the market are actively seeking ways to capitalize on this trend. PanTheryx, a U.S.-based pharmaceutical company, exemplifies this approach by announcing that its bovine colostrum products have received the GRAS (Generally Recognized as Safe) designation from the FDA. This U.S.-specific regulatory approval for ingredients in foods and beverages significantly enhances the credibility of manufacturers in the bovine colostrum market and is a catalyst for market expansion. The market is projected to reach a revenue of approximately USD 4.3 billion by 2027.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=66248

Expanding Applications in Functional Foods and Beverages
The increasing consumer awareness of the health benefits of bovine colostrum, particularly its role in boosting immunity, has led to its incorporation into various functional foods, beverages, and nutrition bars. The functional food segment is poised to lead the global market, with manufacturers ramping up production to introduce bovine colostrum in products like yogurts and dietary supplements. This trend is a key driver of market growth, as consumers seek functional foods that offer substantial health benefits.

Dietary Supplements and Infant Formula Supplementation: Incremental Opportunities
Bovine colostrum supplements are gaining popularity for their potential in treating common ailments and diseases, prompting companies to increase production capacities for dietary supplements. The dietary supplements segment is expected to generate the third-highest revenue in the bovine colostrum market. Manufacturers are focused on incorporating sufficient immunoglobulins in dietary supplements to enhance human digestive health.

Beyond dietary supplements, bovine colostrum is also being incorporated into infant formula, providing a crucial supplement for extremely preterm infants when maternal milk is insufficient. Healthcare providers recommend bovine colostrum supplementation to boost enteral protein intake in preterm infants without apparent adverse effects. This application is creating substantial opportunities for market growth.

𝗖𝗹𝗶𝗰𝗸 𝗵𝗲𝗿𝗲 𝘁𝗼 𝘃𝗶𝗲𝘄 𝘁𝗵𝗲 𝗰𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗿𝗲𝗽𝗼𝗿𝘁 𝗶𝗻 𝗳𝘂𝗹𝗹 𝗱𝗲𝘁𝗮𝗶𝗹 - https://www.transparencymarketresearch.com/bovine-colostrum-market.html

Human Versus Bovine Colostrum: Comparative Benefits
The bovine colostrum market is anticipated to grow at a CAGR of approximately 6.4% during the forecast period. While human colostrum is essential for brain development and intestinal health in infants, it is often insufficient for physiological growth in some cases. Bovine colostrum, rich in essential nutrients, plays a pivotal role in brain development and fluid regulation for infants. Despite its benefits, there is ongoing debate about the use of bovine colostrum, especially for adults, with some arguing that it is more beneficial for newborn calves. Manufacturers are therefore focusing on targeting bovine colostrum products to support the well-being of preterm infants and other necessary applications.

Strategic Alliances and Innovations
Companies in the bovine colostrum market are forming strategic alliances to innovate and expand bovine colostrum-based therapies. Notable collaborations, such as the agreement between APS Bio Group and VitaDairy, highlight the industry's efforts to produce and supply bovine colostrum ingredients for various applications. The concept of proprietary colostrum is intensifying competition, driving manufacturers to integrate bovine colostrum into dairy products and other goods to enhance public health, particularly in emerging economies. The Asia Pacific region, excluding Japan, is expected to generate the highest revenue, reflecting the region's focus on improving consumer health.

Market Overview and Trends
The global bovine colostrum market was valued at approximately USD 2.6 billion in 2019 and is projected to reach USD 4.3 billion by 2027. The market's growth is driven by the increasing demand for functional foods, which promote the growth of beneficial bacteria and offer numerous health benefits. Bovine colostrum-based functional foods are rich in proteins, carbohydrates, lipids, and immunoglobulins, making them attractive to health-conscious consumers.

Additionally, the use of colostrum in animal nutraceutical products is on the rise, offering protection against infections caused by various pathogens. The immunoglobulin in colostrum binds to and inactivates pathogens, safeguarding animals from infections. The powder and tablet forms dominate the market, accounting for approximately 66.4% of the market share in 2019, with functional food, sports nutrition, and pharmaceuticals being key end-use segments.

Sports Nutrition and Infant Formula: Driving Market Growth
The demand for bovine colostrum in sports nutrition products is increasing due to its ability to prevent upper respiratory and intestinal injuries, boost immunity during extreme physical activities, and reduce stress. These benefits have made bovine colostrum a preferred ingredient among athletes and fitness enthusiasts.

Furthermore, the rising demand for bovine colostrum-based infant formula is evident in both developed and developing countries. Colostrum's high nutritional value and ease of digestion make it an essential supplement for infants, protecting their gastrointestinal tract and strengthening their immune system. The inclusion of colostrum in infant formula products is expected to drive market growth significantly.

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 | 𝐈𝐦𝐦𝐞𝐝𝐢𝐚𝐭𝐞 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐚𝐭 - https://www.transparencymarketresearch.com/checkout.php?rep_id=66248<ype=S

Strategies and Regional Insights
Key manufacturers in the bovine colostrum market are leveraging online sales channels and offering attractive discounts to boost sales. Innovations such as hormone-free, antibiotic-free, and GMO-free products are gaining traction. For instance, Biochem Additives launched a new product, B.I.O.Ig Energy 15% Bovine Colostrum Powders, designed to enhance passive immunity and intestinal health in young animals.

North America leads the global market, followed by Asia Pacific excluding Japan, which is expected to retain its position due to the region's focus on consumer health. The conventional segment dominates the market, accounting for approximately 87% of the total share, with the organic segment capturing the remaining share.

𝗔𝗯𝗼𝘂𝘁 𝗨𝘀 𝗧𝗿𝗮𝗻𝘀𝗽𝗮𝗿𝗲𝗻𝗰𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

𝗖𝗼𝗻𝘁𝗮𝗰𝘁:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.